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Biochemical analysesAbstract This study evaluates the antibacterial activity of diethyl ether, methanol, ethanol and
chloroform extracts of red algae Ceramium rubrum (Rhodophyta), Sargassum vulgare, Sargassum
fusiforme and Padina pavonia (Phaeophyta) collected from Red sea, Egypt. The algal extracts were
tested for their antibacterial activity against ten multidrug resistant clinical isolates of Gram
positive and Gram negative bacteria. The highest inhibition activity among all extracts was
obtained with 100 ll diethyl ether extract S. fusiforme against Staphylococcus aureus 2 and 50 ll
ethanol extract of S. vulgare against Klebsiella pneumoniae. The algal extract of S. fusiforme and
S. vulgare was characterized by Gas chromatography–mass spectrometry (GC–MS). The com-
pounds with antimicrobial activity were identified, such as phenols, terpenes, acetogenins, indoles,
fatty acids and volatile halogenated hydrocarbons. Transmission electron microscopy was applied
for determining the morphological changes in S. aureus 2 and K. pneumonia treated with 100 ll
diethyl ether extract of S. fusiforme and 50 ll ethanol extract of S. vulgare, respectively. Perforation
of cell wall, leakage of cytoplasmic contents, severe distortion of outer cell shape, inner chromatin
mild scattered cytoplasmic vacuolation, rupture of cell wall, and decreased cell size for both bacte-
rial isolates treated with 100 ll diethyl ether of S. fusiforme extract and 50 ll S. vulgare ethanolic
extract were recorded.
 2015 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Various natural antimicrobial compounds have been
recorded in marine environment more than those in the ter-
restrial one (Ireland et al., 1988). Marine organisms such asmarine algae are source material for structurally unique nat-
ural products with pharmacological and biological activities
(Schwartsmann et al., 2001). Among the marine organisms,
the macroalgae (seaweeds) occupy a special site as a source
of biomedical compounds (Manilal et al., 2010). Seaweeds
have been recognized as potential sources of the antibiotic
substances. Synthesis of different metabolites from seaweeds
is an indicator of the presence of antimicrobial active com-
pounds (Chiheb et al., 2009). A wide range of bioactive
compounds were derived from macro algae such as antibac-
terial active compounds (Lustigman and Brown, 1991). Sea-
weeds contain many different secondary metabolites which
66 S.M. El Shafay et al.have a wide spectrum of biological activities. It was
observed, the presence of cytostatic, antiviral, anthelminthic,
antifungal and antibacterial activities compounds in green,
brown and red algae with cytostatic, antiviral, anthelminthic,
antifungal and antibacterial activities (Lindequist and
Schweder, 2001; Newman et al., 2003 and Chakraborthy
et al., 2010). Seaweeds are considered to be the main source
of bioactive compounds with a wide range of biological
activities, such as antibiotics, antioxidant and anti-
inflammatory (Tuney et al., 2006; Patra et al., 2008). Some
macroalgae have bio-active components which affected the
germination of some pathogenic bacteria (Kolanjinathan
et al., 2009). Hornsey and Hide (1985) found that many spe-
cies of marine algal crude extracts have inhibition activity
against pathogenic bacteria. Seaweeds contain different sub-
stances which incorporated medicine and pharmacotherapy,
whereas some of the isolated substances have bacteriostatic
and bactericidal properties (Gorban et al., 2003). Different
diseases were treated with antibiotics, extracted from terres-
trial sources that were used as therapeutic agents; new com-
pounds were present in oceans and have commercial value
(Smit, 2004).
Clinical and public health problem due to antibiotic resis-
tance and multi-resistant bacteria are difficult and sometimes
impossible to treat (Levy, 2002). Using antibiotics in differ-
ent medicines has a significant role in the emergence of bac-
terial strains resistant to antibiotics (Bacon et al., 2000).
Recently, new mechanisms of resistance have resulted in
the simultaneous development of resistance to several antibi-
otic classes creating very dangerous multidrug resistant
(MDR) bacterial strains, some also known as ‘‘superbugs”
(Sande-Bruinsma et al., 2008). The required number of
new antimicrobial agents is higher than ever due to the
rapid presence of new infections, emergence of multidrug
resistance in common pathogens, and the potential for use
of multidrug-resistant agents in bioweapons (Peters et al.,
2008). Organisms resistant to more than one class of antimi-
crobial agents are identified as multidrug resistant organisms
(MDROs) (Sameera et al., 2010).
This work aims to evaluate the antimicrobial activity of
some seaweeds extracts from Red sea coast against some col-
lected clinical multidrug resistant bacterial isolates in order
to find alternative drugs and promising source of pharmaceu-
tical agents.Material and methods
Algal collection and preparation
Four seaweeds species, Ceramium rubrum (Rhodophyta),
Sargassum vulgare, Sargassum fusiforme and Padina pavonia
(Phaeophyta) were collected from Hurghada coastal along
the Red sea, Egypt, and identified according to Aleem
(1993). Different species of collected algae were cleaned with
seawater to remove impurities. The seaweeds were trans-
ported to the laboratory in sterile polythene bags. In the
laboratory, samples were rinsed with tap water and were
shade dried, cut into small pieces and powdered in a mixer
grinder.Preparation of organic algae extracts
Different organic solvents (ethanol, methanol, chloroform and
diethyl ether) were used for extraction. Five grams of each
powdered sample were soaked in 40 ml of the solvent for three
days. Remain extracts were filtered and concentrated in a rota-
tory evaporator at 35 C. The residual water was removed with
a vacuum pump. The weighted crude extracts were suspended
in the dimethyl sulfoxide (DEMSO) to a final concentration of
50 mg/ml and stored in a refrigerator (Mohanta et al., 2007;
Patra et al., 2008).
Collection of bacteria
Two isolates of Pseudomonas aeruginosa (PA1 and PA2) were
recovered and identified by Khalil et al. (2015). Four isolates
of Staphylococcus aureus (SA1, SA2, SA3 and SA4), Shigella
flexneri, Escherichia coli, Klebsiella pneumoniae, and
Corynebacterium sp. Bacterial species were brought from
microbiology collection, Faculty of Pharmacy, Tanta Univer-
sity, Egypt. The morphological and biochemical tests were car-
ried out continuously to ensure purity (Collee et al., 1996).
Antibiotic susceptibility testing
The antimicrobial susceptibility of the collected bacteria was
assessed using the modified Kirby-Bauer disk diffusion method
according to the Clinical and Laboratory Standards Institute
(CLSI, 2012). The following concentrations of antibiotics were
tested: Ampicillin (AMP, 10 lg), Amoxicillin (AX, 25 lg),
Amoxycillin/Clavulanic acid (AMC, 20/10 lg), Oxacillin
(OX, 1 lg), Piperacillin-tazobactam (TPZ, 100/10 lg), Ceftazi-
dime (CAZ, 30), Cefepime (FEP, 30 lg), Ceftriaxone (CRO,
30 lg), Imipenem (IPM, 10 lg), Meropenem (MEM, 10 lg),
Cefoperazone/sulbactam (CES, 75/30 lg), Aztreonam (ATM,
30 lg), Gentamicin (CN, 10 lg), Amikacin (AK, 30 lg),
Neomycin (N, 30 lg), Streptomycin (S, 10 lg), Tobramycin
(TOB, 10 lg), Kanamycin (K, 30 lg), Chloramphenicol (C,
30 lg), Colistin Sulfate (CT, 10 lg), Nalidixic acid (NA,
30 lg), Ciprofloxacin (CIP, 5 lg), Co-trimoxazole (SXT,
25 lg), Tetracycline (TE, 30 lg), Vancomycin (VA, 30 lg).
The antibiotic disks were then applied to the prepared
plates and incubated at 37 C for 18 h then, the diameter of
the growth inhibition zones was measured. The multiple
antibiotic resistances (MAR) index was calculated for each
isolate by dividing the number of antibiotics to which the
isolate is resistant by the total number of antibiotics tested
(Krumpernam, 1983; Olayinka et al., 2009; Jayaraman et al.,
2012).
Ultra-structure of multiple drug resistant (MDR) bacterial
isolates
The changes in ultra-structure of selected MDR, S. aureus 2
and K. pneumoniae, due to algal extract treatment were inves-
tigated by transmission electron microscope (JEOL-JEM-
100SX, Japan). The samples were incubated by shaking at
37 C for 18 h followed by centrifugation, and washing using
saline solution (Richards and Cavill, 1976).
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The MIC algal extract against the selected multi-drug resistant
isolate was carried out using a modified procedure from Peng
et al. (2010). Algal extracts were serially diluted with dimethyl
sulfoxide (DMSO) to obtain diluted concentrations in the
range of 50, 75 and 100 ll. Each plate was inoculated with
100 ll of standardized inoculums (106 cfu/ml) of the tested
microorganisms separately, incubated at 37 C for 18 h. The
MIC was defined as the lowest concentration at which no vis-
ible growth was observed. The experiment was performed in
triplicates.
Gas chromatography–mass spectrometry (GC–MS)
The composition of the promising algal extract was obtained
using GC–MS (Agilent 6890 GC coupled to an Agilent 5975
quadrupole mass detector). The SPME fiber was desorbed in
GC injector at 220 C for 5 min in splitless mode and chro-
matographic separation was carried out on a
30 m  0.25 mm  0.25 lm film thickness HP-5MS (5% Phe-
nyl Methyl Siloxane) capillary column. The GC oven temper-
ature was programed from 60 C to 250 C at a rate of
2 C min1. Helium was used as a carrier gas at a constant flow
of 0.9 ml min1. Relative area values (as a percentage of total
volatile composition) were directly obtained from total ion
current (TIC).
Statistical analysis
Results are presented as the mean ± standard deviation (SD)
of three replicates. The statistical analyses were carried out
using SAS (v 6. 12). Data obtained were analyzed statistically
to determine the degree of significance using a one way analy-
sis of variance (ANOVA) at probability level p 6 0.05.
Results and discussion
Resistance of bacterial isolates to different tested antibiotics is
shown in Table 1. The incidence of resistance to different
tested antibiotics ranged between 18.3% (tobramycin) and
100% (ampicillin, amoxicillin, cefepime and kanamycin).
For, penicillins, the incidence of resistance to ampicillin, piper-
acillin and amoxicillin was 100%, 31.7% and 100%, respec-
tively. Mixing clavulanate with amoxicillin and ticarcillin
reduced resistance percentages to 99%.
In the case of cephalosporins, the incidence of resistance
ranged between ceftizoxime (99%), cefotaxime (97.1%), ceftri-
axone (96.1%), cefoperazone (86.5%) and ceftazidime (81.7%)
among 3rd generation cephalosporins. On the other hand, high
percentages (100%) of isolates showed resistance to cefepime
(4th generation cephalosporin). Declined resistance percentage
was detected for imipenem and meropenem to be 45.2% and
37.5% respectively. Resistance to aztreonam was observed in
76% of the tested isolates. The resistance of Pseudomonads
to colistin sulfate (lipopeptide) was moderate (59.6%). The iso-
lates also showed resistance to phenicol antibiotics, such as
chloramphenicol (99%), 97.1% to co-trimoxazole (folate path-way inhibitor). In addition 93.3% of isolates were resistant to
tetracycline (from tetracyclines). In case of ciprofloxacin (fluo-
roquinolone), the incidence of resistance was declined to
29.8%.
Regarding the aminoglycosides the incidence of resistance
of tested isolates ranged between 18.3% and 100% in which
most isolates showed resistance to kanamycin (100%), neomy-
cin (99%), streptomycin (97.1%) followed by declined resis-
tance to amikacin (35.6%), gentamicin (34.6%) and
tobramycin (18.3%) which was found to be the most active
antibiotic against the tested P. aeruginosa isolates.
The MAR (multi-antibiotic resistance) index analysis
revealed that all tested isolates had a very high MAR index
value (>0.2) which indicated that the MAR values are an indi-
cation of the extent of microbial exposure to antibiotics used
within the community (Olayinka et al., 2009). The resistance
of the tested isolates ranged from 36% to 96% (Table 1). On
observing the multidrug resistance (MDR), it was found that
all the tested bacterial isolates showed high frequency multiple
drug resistance (MDR) (9–24 agents). The widespread use of
antibiotics has been identified as a main factor responsible
for the increased incidence of antibiotics resistance (Khalil
et al., 2015). Multiple antibiotic resistance index (MAR) was
used in analyzing health risk and to test the resistance of
antibiotic. Janda (2002) reported that many bacterial strains
are known to harbor mobile elements that encode antibiotic
resistance and can be transferred among themselves or to other
bacterial species, to evolve multiple antibiotic resistances.
Agar well diffusion method was carried out to test the
antibacterial activities of organic extracts of four collected
marine species and the data are tabulated in Table 2. Diethyl
ether extract of S. vulgare showed inhibition activity against
S. flexneri, E. coli and P. aeruginosa 1 only. However, the
methanol extract of S. vulgare did not show any a noticeable
activity against the multidrug resistant bacteria tested except
K. pneumoniae and S. flexneri. Ethanol extracts of S. vulgare
show inhibition activity against P. aeruginosa 2 and high activ-
ity against K. pneumoniae while, chloroform extract of S. vul-
gare shows activity against P. aeruginosa 2, K. pneumoniae
and S. aureus 1. Compared to water based methods organic
solvent has a higher efficiency in extracting compounds for
antibacterial activities (Tuney et al., 2006). Rajasulochana
et al. (2009) concluded that chloroform: methanol is one of
the main solutions for extracting the active antibacterial mate-
rials from the brown algae species. The methanol extracts of S.
vulgare do not have antibacterial activity against E. coli and S.
aureus growth as indicated by Ibtissam et al. (2009). Silva et al.
(2013) found that E. coli and P. aeruginosa were affected only
by the ethanolic extract of the brown seaweed Padina gym-
nospora. Antibacterial activities of algal extracts depend on
algal species, the efficiency of the extraction method and con-
centration of the extract. For instance, diethyl ether extract of
S. fusiforme shows high activity against most tested species
specially S. aureus 2; however, the methanol extract of S. fusi-
forme shows inhibition activity against P. aeruginosa 1 and 2
(Table 2). Ethanol extract of S. fusiforme affected S. flexneri,
S. aureus 3 and P. aeruginosa 1 and 2. In this investigation,
chloroform extract of S. fusiforme showed high significant
activity against K. pneumoniae and S. aureus 2.
Table 1 Overall antibiotic resistance profiles (ARPs) for the clinical bacterial isolates.
Code of
antimicrobial
agent
Pseudomonas
aeruginosa 1
Staphylococcus
aureus 1
Staphylococcus
aureus 2
Staphylococcus
aureus 3
Pseudomonas
aeruginosa 2
Klebsiella
pneumonia
Shigella
flexneri
Escherichia
coli
Staphylococcus
aureus 4
Corynebacterium
sp.
TZP S S R R S R S S R R
TOB S S R S S R S R S R
AM R R R R R R R R R R
NA R R R R R R S R S R
CES R S R R R R R R R R
S R S R S R S S R R R
K R S R S R R S R R R
FEP R R R R R R R R R R
CIP S S S S S R S R R R
VA R S S S R R S R R R
AX R S R R R R R R R R
OX R R R R R R R R R R
C R S R S R R S S R R
CN S S S S S R S S R R
CRO R R R R R R R R R R
CAZ S R R R S R R R R R
IPM S S R S S R S S S R
AK R S R S S R S S S R
MEM S S R S S R S S S R
AMC R S R S R R R R S R
TE S R R R S R S R R R
ATM S R R R S R R R R R
N R S S S S R S R S S
CT R R R R R R R R R R
SXT R S R S R R R R S R
MAR index 0.64 0.36 0.84 0.48 0.56 0.96 0.44 0.76 0.68 0.96
R = resistant, S = sensitive.
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Table 2 Incidence of antimicrobial resistance among bacterial
isolates (n= 10).
Antimicrobial agent No. (%) of resistant isolates
b-Lactams
Ampicillin (AMP) 10 (100%)
Amoxicillin (AX) 9 (90%)
Cefoperazone/sulbactam (CES) 9 (90%)
Amoxycillin/clavulanic acid (AMC) 7 (70%)
Piperacillin-tazobactam (TZP) 5 (50%)
Ceftazidime (CAZ) 8 (80%)
Cefepime (FEP) 10 (100%)
Ceftriaxone (CRO) 10 (100%)
Imipenem (IPM) 3 (30%)
Meropenem (MEM) 3 (30%)
Aztreonam (ATM) 8 (80%)
Aminoglycosides
Gentamicin (CN) 3 (30%)
Amikacin (AK) 4 (40%)
Neomycin (N) 3 (30%)
Streptomycin (S) 6 (60%)
Tobramycin (TOB) 4 (40%)
Kanamycin (K) 7 (70%)
Fluoroquinolones
Ciprofloxacin (CIP) 4 (40%)
Folate pathway inhibitors
Co-trimoxazole (SXT) 7 (70%)
Tetracyclines
Tetracycline (TE) 7 (70%)
Phenicols
Chloramphenicol (C) 6 (60%)
Lipopeptides
Colistin sulfate (CT) 10 (100%)
Glycopeptides
Vancomycin (VA) 6 (60%)
Antimicrobial activity of some seaweeds species 69In the present study, all extracts of P. pavonia show signif-
icant inhibition activity for most tested bacteria. The maxi-
mum inhibition activity was observed with ethanol extract of
P. pavonia against K. pneumonia and S. flexneri. Diethyl ether
extract of C. rubrum shows antibacterial activity against nearly
all tested species. Data also revealed that Gram positive and
Gram negative bacteria were affected by MICs ranged from
50 to 100 mg/ml of the tested algal extracts. Different concen-
trations of methanol extract of C. rubrum show activity against
S. flexneri, E. coli, P. aeruginosa 2 and K. pneumoniae. As
observed from Table 3 ethanol extract of C. rubrum showed
inhibition activity against P. aeruginosa 1, S. aureus 1, S. flex-
neri and S. aureus 4. Chloroform extract of C. rubrum signifi-
cantly affected S. flexneri, P. aeruginosa 2 and K. pneumoniae.
El-Sheekh et al. (2014) reported that Dictyota sp. extract has
low antibacterial activity against some Gram positive bacteria;
the inhibition zone (17 mm) of S. aureus 1 followed by lower
growth inhibition of Staphylococcus pneumoniae, S. aureus 2
and Streptococcus viridians. In this study, the antimicrobial
activities of four algal extracts prepared by ethanol, diethylether, chloroform and methanol, were studied against some
multidrug resistant bacteria. All algal extracts have different
inhibition levels of the tested microbial growth. Among the
algal samples screened for antibacterial activity, the organic
extract of all algal species has high activity against S. aureus
4 at conc. 100 ll. These seaweeds act as potential bioactive
compounds of interest for pharmaceutical applications
(Solomon and Santhi, 2008). Hodgson (1984) reported antimi-
crobial activity of seaweeds belonging to Chlorophyta, Phaeo-
phyta and Rhodophyta. A number of marine algae from
eastern Sicily like Dictyota dichotoma, Cystoseira elegans and
Laurencia obtusa showed antibacterial activity (Caccamese
and Azzolina, 1979).
As observed from Table 2, 100 ll diethyl ether extract of S.
fusiforme showed the highest activity against S. aureus 2 than
all tested antimicrobial agents. Data also showed that 50 ll
ethanol extract of S. vulgare recorded the highest activity
against K. pneumonia. In addition 100 ll diethyl ether extract
of S. fusiforme and 50 ll ethanol extract of S. vulgare showed
maximum inhibition activity. The presence of different
antibacterial substances in the organic solvent extracts from
the tested species may be the reason for the variation of
antibacterial activity as reported by Lustigman and Brown
(1991).
The GC–MS chromatograms showed various compounds
present in diethyl ether extract from S. fusiforme and ethanol
extract of S. vulgare. Names of these components and their
amounts are listed in Tables 4 and 5; Figs. 1 and 2. The
antibacterial activity of the 100 ll diethyl ether extract of S.
fusiforme and 50 ll ethanol extract of S. vulgare might be
attributed to a wide range of chemical classes, including
indoles, terpenes, acetogenins, phenols, fatty acids and volatile
halogenated hydrocarbons. The two extracted included high
percentage of Octadecadienoic acid, Eicosane, Dotriacontane,
Tritetracontane, Docosane, Octatriacontyl, Heptacosane and
Tetracosane. These compounds have been already proposed
to have a certain antimicrobial activity (Alagic et al., 2006).
Phlorotannins, phenolic compounds and diterpenediol (crini-
tol) are reported to be produced by brown algae Sargassum
critaefolium, Sargassum tortile, Ecklonia kurome, Eisenia bicy-
clis and Cystoseira crinite exhibited antibacterial activity
(Alam et al., 1994; Nagayama et al., 2002). Generally, the ear-
lier studies found Gram positive was affected by algal extracts
activity more than Gram negative bacteria; this may be due to
the complex structure of the cell wall of Gram negative bacte-
ria (Stirk et al., 2007). Many species of macro algae had fore-
most constituents like tetradecanoic acid, hexadecanoic acid,
octadecanoic acid methyl esters etc. (Balamurugan et al.,
2013) (see Table 5).
Photo (1 and 2) illustrated the intact cytoplasm and bacte-
rial cell wall structures of none treated MDR K. pneumoniae
and S. aureus 2 vegetative cells. Treated cells revealed high
destructive effect of diethyl ether extract of S. fusiforme and
ethanol extract of S. vulgare, as it caused perforation of cell
wall, leakage of cytoplasmic contents and severe distortion
of outer cell shape for both bacterial isolates. On the other
hand, S. aureus 2 cells were less affected by the treatment with
both 100 ll diethyl ether extract of S. fusiforme, as they cause
slight shrinking of protoplasm cytoplasmic vacuolation and
Table 3 Antibacterial activity of some seaweeds against multidrug resistant bacteria.
Algal species Organic solvents Pseudomonas aeruginosa 1 Staphylococcus aureus 1 Staphylococcus aureus 2
50 75 100 ll 50 75 100 ll 50 75 100 ll
Sargassum vulgare Diethyl ether 14.67 ± 0.57b 0a 0a 0a 0a 0a 0a 0a 0a
Methanol 0a 0a 0a 0a 0a 0a 0a 0a 0a
Ethanol 0a 0a 0a 0a 0a 0a 0a 0a 0a
Chloroform 0a 0a 0a 11.83 ± 0.76b 0a 0a 0a 0a 0a
Sargassum fusiforme Diethyl 23.33 ± 0.57c 18.33 ± 0.57b 0a 14 ± 1c 13 ± 1c 0a 15.33 ± 0.57b 0a 0a
Methanol 14.67 ± 0.57e 9.33 ± 0.57d 0a 0a 0a 0a 0a 0a 0a
Ethanol 11.67 ± 0.57f 0a 0a 0a 0a 0a 0a 0a 0a
Chloroform 0a 0a 0a 0a 0a 0a 15.5 ± 0.5b 0a 0a
Padina pavonia Diethyl 15.67 ± 0.57c 13.33 ± 0.57b 0a 14.67 ± 0.57b 0a 0a 0a 0a 0a
Methanol 0a 0a 0a 0a 0a 0a 18.33 ± 0.57c 11.33 ± 0.57b 0a
Ethanol 15.67 ± 0.57c 12.67 ± 0.57d 0a 20.33 ± 0.57e 16.33 ± 0.57d 11.67 ± 0.57c 0a 0a 0a
Chloroform 16.33 ± 0.57c 13.67 ± 0.57b 0a 0a 0a 0a 8.5 ± 0.5b 0a 0a
Ceramium rubrum Diethyl 15.67 ± 0.57c 13.33 ± 0.57b 0a 16.33 ± 0.57c 13.33 ± 0.57b 11.33 ± 0.57a 8.33 ± 0.28b 0a 0a
Methanol 0a 0a 0a 0a 0a 0a 0a 0a 0a
Ethanol 13.33 ± 0.57b 0a 0a 8.33 ± 0.57e 0a 0a 0a 0a 0a
Chloroform 0a 0a 0a 0d 0a 0a 0a 0a 0a
DMSO DMSO – – – – – – – – –
Algal species Organic
solvents
Shigella flexneri Escherichia coli Staphylococcus aureus 4 Corynebacterium sp.
50 75 100 ll 50 75 100 ll 50 75 100 ll 50 75 100 ll
Sargassum
vulgare
Diethyl 14.67 ± 0.57c 10.67 ± 0.57b 0a 13.67 ± 0.57c 10.67
± 0.57b
0a 0a 0a 0a 0a 0a 0a
Methanol 14.67 ± 0.57c 13.7 ± 0.57d 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Ethanol 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Chloroform 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Sargassum
fusiforme
Diethyl 12.67 ± 0.57b 0a 0a 0a 0a 0a 0a 0a 0a 9.67 ± 0.57b 0a 0a
Methanol 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Ethanol 9.67 ± 0.57d 8.67 ± 0.57c 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Chloroform 11.67 ± 0.57e 0a 0a 0a 0a 0a 20.67 ± 0.57b 0a 0a 0a 0a 0a
Padina
pavonia
Diethyl 9.67 ± 0.57b 0a 0a 0a 0a 0a 11.33 ± 0.57c 8.67
± 0.57b
0a 12.67 ± 0.5c 9.67
± 0.57b
0a
Methanol 9.67 ± 0.57b 0a 0a 0a 0a 0a 16.67 ± 0.57d 0a 0a 0a 0a 0a
Ethanol 20.67 ± 0.57c 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
Chloroform 11.67 ± 0.57d 0a 0a 15.67 ± 0.57b 0a 0a 0a 0a 0a 11.67 ± 0.5d 0a 0a
Ceramium
rubrum
Diethyl 11.67 ± 0.57c 9.67 ± 0.57b 0a 11.67 ± 0.57b 0a 0a 15.67 ± 0.57b 0a 0a 0a 0a 0a
Methanol 11.67 ± 0.57c 0a 0a 15.67 ± 0.57c 0a 0a 0a 0a 0a 0a 0a 0a
Ethanol 17.67 ± 0.57e 13.67 ± 0.57d 0a 0a 0a 0a 15.67 ± 0.57b 0a 0a 0a 0a 0a
Chloroform 13.33 ± 0.57f 10 ± 0.57b 0a 0a 0a 0a 0a 0a 0a 0a 0a 0a
DMSO DMSO – – – – – – – – – – – –
Values with the same letter in each separate parameter are significant (one-way above).
7
0
S
.M
.
E
l
S
h
a
fa
y
et
a
l.
Table 4 Composition of the Sargassum fusiforme diethyl ether
extract as investigated by GC–MS chromatography.
No. Compounds R.
time
Percentage
(%)
1 10,13-Octadeadienoic acid 31.61 9.43
2 Tritriacontane 32.315 5.08
3 2-Butyloctanol 33.38 7.22
4 Pentacosane 33.672 4.54
5 Eicosane 35.733 15.18
6 Dotriacontane 36.866 10.38
7 Octatriacontyl
pentafluoropropionate
37.25 2.13
8 Nonacosane 38.002 12.13
9 Hentriacontane 38.475 2.5
10 Tritriacontane 38.809 1.38
11 Eicosane 39.396 9.9
12 Tricosane 39.882 1.5
13 Dicosane 40.997 9.8
14 Pentatriacontane 45.268 5.3
15 Eicosane, 2-methyl 48.169 3.37
Table 5 Composition of the Sargassum vulgare ethanolic
extract as investigated by GC–MS chromatography.
No. Compounds R. time Percentage (%)
1 Cyclopentaneacetic acid 20.466 6.42
2 Tonalid 27.006 2.63
3 Tetratetracontane 35.734 5.02
4 Di-n-octyl phthalate 37.67 48.26
5 Octacosane 38.06 3.55
6 Heneicosane 39.4 9.61
7 Pentacosane 41.002 6.96
8 Docosane 42.946 6.69
9 Tetracosane 45.329 5.99
10 Heptacosane 48.247 4.83
Antimicrobial activity of some seaweeds species 71distortion of outer cell boundary, 100 ll diethyl ether extract
of S. fusiforme possessed increased cell size and protoplasmic
agglutinations (Photo 2). While K. pneumonia showed cell wall
dissolving with cytoplasmic leakage and alteration in cytoplas-Figure 1 GC–MS chromatogram of Sarmic density, decrease in cell size and deformation in cell struc-
ture on the treatment with 50 ll ethanol extract of S. vulgare
showed mild scattered cytoplasmic vacuolation, rupture of cell
wall, and decreased cell size (Photo 1). Diethyl ether and etha-
nol extract from S. fusiforme and S. vulgare, respectively
caused complete degradation and cell wall deformation in both
treated MDR bacteria S. aureus 2 and in K. pneumoniae these
variations might be due to genetic or biochemical composition
of pathogenic bacteria (Caccamese et al., 1981). This result
might be due to clinical bacterial cell wall that contains a high
percentage of (90–95%) of peptidoglycan and has lipopolysac-
charides and phospholipids (5–10) inside the G +ve cell and
destroys the cell membrane or protein biosynthesis units
(DNA and RNA) as compared to G ve germs whose mem-
brane consists of two layers (outer and inner membrane) sep-
arated by periplasmic space. The outer membrane consists of
phospholipids, lipoprotein and muco-polysaccharides while
the internal membrane consists of peptidoglycan (glycopep-
tide) (5–10%); it means the membrane of G ve cell has high
percentage of lipids (90–95%), which does not support and
does not have an appropriate medium to interact with and
enter the antimicrobial agents and then decreased its influence
on the pathogenic bacteria (Al-Samary, 1999).Conclusion
The solvent extracts of four different seaweeds used in the pre-
sent study showed significant inhibitory action against MDR
bacteria. Among the four seaweeds screened for their antibac-
terial activity, the 100 ll diethyl ether extract of brown alga S.
fusiforme and 50 ll ethanol extract of S. vulgare showed more
inhibitory activity against S. aureus 2 and K. pneumoniae,
respectively. The phytochemical screening of seaweeds showed
the presence of indoles, terpenes, acetogenins, phenols, fatty
acids and volatile halogenated hydrocarbons in the selected
species. The changes in ultrastructure of tested MDR bacteria,
S. aureus 2 and K. pneumoniae, due to S. fusiforme and S. vul-
gare extract were investigated by transmission electron micro-
scope which shows shrinking of protoplasm cytoplasmic
vacuolation deformation in cell structure and distortion of
outer cell boundary.gassum fusiforme diethyl ether extract.
Figure 2 GC–MS chromatogram of Sargassum vulgare ethanolic extract.
A
B
C 
Photo 1 (A) Klebsiella pneumonia control, (B) and (C) damaged
K. pneumonia treated 50 ll ethanol extract of Sargassum vulgare.
A
B
C
Photo 2 (A) Staphylococcus aureus 2 control, (B) and (C)
damaged treated with 100 ll diethyl ether extract of Sargassum
fusiforme.
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